North Shore-LIJ Receives Accreditation on Human Research

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
North Shore-LIJ Receives Accreditation on Human Research Protection

MANHASSET, N.Y., Dec. 23, 2013 (GLOBE NEWSWIRE) -- The North Shore-LIJ Health System has been awarded accreditation from the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP). AAHRPP is a nonprofit organization that provides accreditation for organizations that conduct human research and can demonstrate that their protections exceed the safeguards required by the US government. The health system has shown that it follows rigorous standards for ethics, quality and protections for human research.

"Across the North Shore-LIJ Health System, we are committed to conducting high-quality, ethical research, and ensuring that those who participate in research are protected," said Kevin J. Tracey, senior vice president of research for the health system and president of The Feinstein Institute for Medical Research, the research arm of the health system. "It is an honor to be awarded AAHRPP accreditation as it signifies our success in this commitment."

Research takes several forms. Scientific or medical research, when successful, results in new medications or devices that could dramatically improve the way certain diseases or conditions are treated. Other research studies use surveys or observe people to gather information about their behavior, opinions, and/or beliefs. The common denominator with all research is human participants, and because research is experimental, some level of risk is involved. The federal government requires researchers to inform participants about any potential risks involved, and to do everything possible to minimize those risks. AAHRPP was established to promote a process of accreditation as a way to improve quality of research and protect research participants. By attaining AAHRPP accreditation, organizations demonstrate they are committed to conducting high-quality research and prioritizing the protection of their participants. Organizations that attain accreditation do so voluntarily and agree to adhere to research standards that, in many cases, are stricter than those set by the federal government.

"To earn accreditation, we underwent a rigorous evaluation process that involved a thorough site visit by experts in human research protection and showed that we have systems in place to monitor the well being of research participants," said Cynthia Hahn, vice president of clinical research and regulatory affairs at the health system. "Ultimately, with AAHRPP accreditation, research participants can trust that health system researchers will prioritize their safety and well-being above all else."

"When an organization earns the AAHRPP seal, it earns a place among the world's most respected, trustworthy research organizations," said Elyse Summers, AAHRPP president and CEO. "AAHRPP accreditation signifies an organization's commitment to the highest level of research protections –all to the benefit of the research participants we are pledged to protect."

For more information about the North Shore-LIJ health system research programs, visit http://www.feinsteininstitute.org/clinical-research/ or call 1-877-GO-NSLIJ (1-877-466-7545).

About North Shore-LIJ Health System

One of the nation's largest health systems, North Shore-LIJ delivers world-class clinical care throughout the New York metropolitan area, pioneering research at The Feinstein Institute for Medical Research and a visionary approach to medical education, highlighted by the Hofstra North Shore-LIJ School of Medicine. North Shore-LIJ cares for people at every stage of life at 16 hospitals, long-term care facilities and nearly 400 outpatient physician practices throughout the region. North Shore-LIJ's owned hospitals and long-term care facilities house more than 6,000 beds, employ more than 10,000 nurses and have affiliations with more than 9,400 physicians. With a workforce of more than 47,000, North Shore-LIJ is the third-largest employer in New York State. For more information, go to www.northshorelij.com .

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer's disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit www.FeinsteinInstitute.org .

A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=22822

Emily Ng 516-562-2670

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence

Updated Category News Views 3

Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...

Continue Reading
Gala Spotlights Veterans' Mental Health Support

Updated Category News Views 8

Champions for Veterans Honored at Headstrong Gala If you ever wondered who stands in the trenches alongside veterans facing mental health battles, this year's Headstrong Gala offered a crystal-clear answer. Held on October 16 at Pier Sixty in New York City, this shiindig wasn’t just about schmoozing over canapés. It was about celebrating the grit and guts of those...

Continue Reading
Navigating Home Sales: Expert Insights from Jodi Kallus

Updated Category News Views 1

Preparing for the Real Estate Rollercoaster Getting ready to sell your home? Let's cut through the noise and get right into the nitty-gritty with Jodi Kallus, a seasoned real estate pro with Summit Realtors. The first step ain't just about slapping a ‘For Sale’ sign on your front lawn. It's about laying down a plan that's as solid as the foundation of the house you're...

Continue Reading
Infosys Pushes AI Growth with Strong Deal Wins

Updated Category News Views 3

Riding the AI Wave Who knew Infosys was a lightning rod for AI momentum, eh? With a 29% quarterly surge in AI revenue, the firm's really putting AI strategy at center stage. Considering today's finicky markets, that's not just peanuts. CEO Salil Parekh's swagger is backed by real numbers, seeing AI revenue inch to 10.5% of total haul. This ain't just talk—Infosys is...

Continue Reading
Ping An Good Doctor Grows 35%: AI's Expanding Role

Updated Category News Views 5

Ping An Good Doctor's Noteworthy Financial Uptick Stop me if you've heard this one: a hefty hike in numbers that make investors straighten up a bit. Ping An Good Doctor did just that, reporting a 35% spark in net profit as the books closed up till September 2026. In a landscape where many health-tech firms merely tread water, these guys rode a wave of RMB 0.25 billion in...

Continue Reading
Palmstreet Amplifies Designer Toys at Las Vegas Con

Updated Category News Views 9

Designer Toys Take the Spotlight Palmstreet's latest move into the designer toy world is buzzing with anticipation. This live-shopping app, initially catering to rare plants, is taking its evolution seriously with another plunge into exclusive collectibles, this time showcasing unique collaborations at DesignerCon in Las Vegas. While Palmstreet may have started in a...

Continue Reading
Lincoln Educational Faces Investor Lawsuit Over Revenue Drop

Updated Category News Views 3

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Continue Reading
Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

Updated Category News Views 1

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

Continue Reading
S&P Global's New Dashboard: Unpacking Data Insights

Updated Category News Views 3

An Interactive Take on Digital Infrastructure The geniuses over at S&P Global Ratings have just unleashed a shiny new tool for number crunchers and market hawks who can't get enough data center action—an interactive dashboard. Maybe not everyone’s cup of tea, but hey, in the dog-eat-dog world of digital infrastructure, any edge counts. What's in the Data Center Soup?...

Continue Reading
Patrick Ta Beauty Adds New Leadership to Expand Growth

Updated Category News Views 2

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Continue Reading

Top 5 Most Recently Viewed Articles

JMGO's O2S Ultra 4K Projector Revolutionizes Home Cinema Experience

Updated Category News Views 175

JMGO Announces the Innovative O2S Ultra 4K Tri-Laser TV Projector JMGO, a leader in optical technology, has unveiled its latest innovation, the O2S Ultra 4K Tri-Laser TV projector. This announcement occurred at a prominent technology event, showcasing JMGO's dedication to advancing home entertainment technology. Transforming Home Viewing with the O2S Ultra 4K The O2S...

Continue Reading
Faircourt Gold Income Corp. Reveals Class A Share Redemption Details

Updated Category News Views 340

Key Details of Faircourt Gold Income Corp.’s Redemption Process Faircourt Asset Management Inc., managing Faircourt Gold Income Corp., has exciting updates for securityholders. For those who opted to redeem their Class A Shares, the net asset value per share is set at $3.9552. This value reflects a calculated average price from the last five trading days, showcasing the...

Continue Reading
BrightSpire Capital's Upcoming Earnings Call and 2024 Results Insight

Updated Category News Views 94

BrightSpire Capital to Release Fourth Quarter Financial Results BrightSpire Capital, Inc. (NYSE: BRSP) has announced an important event for its investors. The company is set to disclose its fourth quarter and full year 2024 financial results on a specified date in February, following the close of the market. This is an exciting time for shareholders, as financial releases...

Continue Reading
Partners Value Split Corp. Expands Preferred Shares Offering to $200M

Updated Category News Views 267

Partners Value Split Corp. Expands Preferred Shares Offering In a significant move reflecting robust investor interest, Partners Value Split Corp. has announced an increase in the public offering of its Class AA Preferred Shares, Series 15. The offering is now set at a remarkable $200 million, showcasing the confidence engendered among investors. Details of the Offering...

Continue Reading
Palvella Therapeutics Advances QTORIN™ Gel for Rare Skin Disorders

Updated Category News Views 166

Palvella's QTORIN™ Gel Unveiled at Pediatric Dermatology Congress In an exciting development for patients suffering from microcystic lymphatic malformations (microcystic LMs), Palvella Therapeutics has announced the presentation of its QTORIN™ rapamycin 3.9% anhydrous gel. This groundbreaking product was featured by Dr. Amy Paller during an oral presentation at a...

Continue Reading